-
441
The Role of Gut Microbiota in Tumor Immunotherapy
Published 2021-01-01“…Some bacteria help fight tumors by activating immunity, while some bacteria mediate immunosuppression to help cancer cells escape from the immune system. …”
Get full text
Article -
442
Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors.
Published 2023-01-01“…We first observed that transplanted human dopaminergic precursors into the striatum of immunosuppressed rats elicited an early and sustained activation of astroglial and microglial cells after 15 days' post-transplant. …”
Get full text
Article -
443
A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy
Published 2021-01-01“…Fetal safety should be considered and risks thoroughly discussed with the patient when choosing an immunosuppressive regimen for this condition.…”
Get full text
Article -
444
Ticam2 ablation facilitates monocyte exhaustion recovery after sepsis
Published 2025-01-01“…Abstract Sepsis is a leading cause of death worldwide, with most patient mortality stemming from lingering immunosuppression in sepsis survivors. This is due in part to immune dysfunction resulting from monocyte exhaustion, a phenotype of reduced antigen presentation, altered CD14/CD16 inflammatory subtypes, and disrupted cytokine production. …”
Get full text
Article -
445
Identifying RBBP7 as a Promising Diagnostic Biomarker for BK Virus-Associated Nephropathy
Published 2022-01-01“…BK virus-associated nephropathy (BKVN) remains a major infectious complication due to powerful immunosuppression in kidney transplant recipients, and its histologic appearance can mimic rejection, leading to diagnostic and treatment dilemmas thus molecular diagnostic methods would be beneficial. …”
Get full text
Article -
446
Tuberculous Osteomyelitis of the Scapular Spine Revealing HIV-1 Infection
Published 2024-12-01“…This rare form of tuberculosis with an exceptional site revealed a HIV infection with profound immunosuppression. The patient was initiated on anti-tubercular treatment according to Moroccan recommendations.…”
Get full text
Article -
447
The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
Published 2024-12-01“…KRAS-G12C, KRAS-G12V, and KRAS-G12D mutations may enhance NSCLC drug resistance through immunosuppression.…”
Get full text
Article -
448
Late Onset Graft Plasmacytoma-Like PTLD Presenting as Acute Hyperglycemia in a Kidney-Pancreas Transplant Recipient
Published 2019-01-01“…We report the case of a 54-year-old simultaneous pancreas-kidney transplant recipient (immunosuppression: OKT3, methylprednisolone, cyclosporine, and azathioprine), diagnosed with an IgG-kappa monoclonal gammopathy of undetermined significance eighteen years after transplant. …”
Get full text
Article -
449
Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
Published 2017-01-01“…In addition, the severe immunosuppression during acute infection described in mice does not occur in the experimentally infected ones. …”
Get full text
Article -
450
Listeria monocytogenes and Staphylococcus aureus coinfection in a patient with multiple myeloma: Case report
Published 2025-01-01“…Conclusion: In conclusion, this case emphasizes the intersection of hematological malignancy, chemotherapy-related immunosuppression, and subsequent severe disseminated bacterial infections and coinfections. …”
Get full text
Article -
451
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
Published 2013-01-01“…The mammalian target of rapamycin inhibitors (mTOR-I), sirolimus and everolimus, are immunosuppressive drugs largely used in renal transplantation. …”
Get full text
Article -
452
Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump
Published 2015-01-01“…It was hypothesized that use of Ruxolitinib through its selective inhibition of Janus-activated kinases 1 and 2 resulted in immunosuppression and miliary tuberculosis in this patient. …”
Get full text
Article -
453
A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity
Published 2022-01-01“…However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. …”
Get full text
Article -
454
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Published 2018-01-01“…Clinical responses to adoptive NK-based immunotherapy have been thwarted, however, by the profound immunosuppression induced by the tumor microenvironment, particularly severe in the context of solid tumors. …”
Get full text
Article -
455
The Correlation between Oral Candida albicans and Interlukine-23 in Diabetic Patients in Hilla City, Iraq
Published 2024-12-01“…Background: Candidiasis is the most common opportunistic fungal infection in the oral cavity. Because of immunosuppression and other physiological changes, diabetes makes people more susceptible to Candida infections. …”
Get full text
Article -
456
Repeated CMV Infection in a Heart Transplantation Patient
Published 2012-01-01“…The patient received different treatments against CMV and the immunosuppression was changed several times. Finally, everolimus was introduced instead of cyclosporine, and mycophenolate mofetil was withdrawn. …”
Get full text
Article -
457
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Published 2018-01-01“…Here, we briefly introduce the mechanism of immunosuppression in hepatocellular carcinoma and summarize the rationale of the four major immunotherapeutic approaches with their current advances.…”
Get full text
Article -
458
Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia
Published 2024-12-01“…Logistic regression model demonstrated positive culture (OR 4.78, P = 0.03), including positive blood culture (OR 8.05, P = 0.003), and GVHD (OR 19.44, P = 0.029), and were associated with high rates of appropriate de-escalation. Immunosuppression (OR 0.22, P = 0.004) was associated with lower rates of appropriate de-escalation. …”
Get full text
Article -
459
Decoding the mechanisms behind second primary cancers
Published 2025-01-01“…This review summarizes recent studies on the mechanisms of SPCs, including the roles of genomic changes after first primary cancer (FPC) treatments, stromal cell phenotypic and metabolic changes, hormone levels and receptor expression, immunosuppression, aberrant gene methylation, EGFR signaling, and cell-free DNA in SPC development. …”
Get full text
Article -
460
Fatal Multiorgan Failure Associated with Disseminated Herpes Simplex Virus-1 Infection: A Case Report
Published 2012-01-01“…Autopsy revealed a predominantly retroperitoneal diffuse large B-cell lymphoma as the suspected origin of immunosuppression underlying herpes simplex dissemination.…”
Get full text
Article